Threshold Pharmaceuticals (THLD) gapped open higher Monday morning and is now up 0.76 at $3.75 in early trade.
Threshold Pharmaceuticals is extending the sharp increase posted on Friday, after the company announced a global agreement with Merck KGaA to co-develop and commercialize TH-302. The stock has set a new high for the year Monday morning, on above average trading volume.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.